Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Prior Therapy with Rituximab (R) in Patients (pts) with Diffuse Large B-Cell Lymphoma (DLBCL) Does Not Affect Disease-Free (DFS) or Overall Survival (OS) Following High Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT).

Snehal G. Thakkar, MD, John William Sweetenham, MD, Lisa Rybicki, Ronald Sobecks, MD, Steven Andresen, DO, Robert M. Dean, MD, Brad Pohlman, MD, Tyler Y. Kang, MD, Matt Kalaycio, MD, Stacey Brown, Brian J. Bolwell, MD

Blood (2006) 108 (11): 3054.

https://doi.org/10.1182/blood.V108.11.3054.3054

Published: 2006

Journal Articles

Prior Therapy with Rituximab (R) in Patients with Follicular Lymphoma (FL) Does Not Affect Relapse-Free (RFS) or Overall Survival (OS) after High Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT).

Tyler Y. Kang, MD, John William Sweetenham, MD, Snehal G. Thakkar, MD, Lisa A. Rybicki, MS, Stacey Brown, Robert Dean, MD, Mikkael A. Sekeres, MD, MS, Anjali Advani, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Brad Pohlman, MD, Brian J. Bolwell, MD

Blood (2006) 108 (11): 3069.

https://doi.org/10.1182/blood.V108.11.3069.3069

Published: 2006

Journal Articles

Survival and Predictors of Outcome in Acute Leukemia Patients Admitted to the Intensive Care Unit.

Snehal G. Thakkar, MD, Zachariah A. McIver, DO, Sanjay R. Mohan, MD, Giridharan Ramsingh, MD, Anjali S. Advani, MD, Ronald Sobecks, MD, Lisa Rybicki, Alejandro Arroliga, MD, Matthew Kalaycio, MD, Mikkael A. Sekeres, MD

Blood (2005) 106 (11): 2778.

https://doi.org/10.1182/blood.V106.11.2778.2778

Published: 2005

Journal Articles

Aggressive Electrolytes Replacement in Multiple Myeloma (MM) Patients Receiving Arsenic Trioxide (ATO) Containing Regimens Alleviates the Need for Frequent Electrocardiogram (ECG) Monitoring.

Toni K. Choueiri, MD, Esteban Walker, PhD, Rachid C. Baz, MD, Rony M. Abou-Jawde, MD, Snehal G. Thakkar, MD, Bridget McGowan, Megan Kelly, Steven Andresen, MD, Mohamad Hussein, MD

Blood (2005) 106 (11): 5155.

https://doi.org/10.1182/blood.V106.11.5155.5155

Published: 2005

Journal Articles

Bisphosphonate Therapy Associated with an Increased Incidence of Mandibular/Maxillary Osteomyelitis in Multiple Myeloma Patients.

Snehal G. Thakkar, MD, Carlos Isada, MD, Kristin Englund, MD, Walter Tomford, MD, Mary Ann Karam, RN, Janice L. Reed, RN, James Smith, DDS, Mohamad A. Hussein, MD

Blood (2004) 104 (11): 4925.

https://doi.org/10.1182/blood.V104.11.4925.4925

Published: 2004

NARROW

Prior Therapy with Rituximab (R) in Patients (pts) with Diffuse Large B-Cell Lymphoma (DLBCL) Does Not Affect Disease-Free (DFS) or Overall Survival (OS) Following High Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT).

Prior Therapy with Rituximab (R) in Patients with Follicular Lymphoma (FL) Does Not Affect Relapse-Free (RFS) or Overall Survival (OS) after High Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT).

Survival and Predictors of Outcome in Acute Leukemia Patients Admitted to the Intensive Care Unit.

Aggressive Electrolytes Replacement in Multiple Myeloma (MM) Patients Receiving Arsenic Trioxide (ATO) Containing Regimens Alleviates the Need for Frequent Electrocardiogram (ECG) Monitoring.

Bisphosphonate Therapy Associated with an Increased Incidence of Mandibular/Maxillary Osteomyelitis in Multiple Myeloma Patients.

Email alerts

ASH Publications

American Society of Hematology

Prior Therapy with Rituximab (R) in Patients (pts) with Diffuse Large B-Cell Lymphoma (DLBCL) Does Not Affect Disease-Free (DFS) or Overall Survival (OS) Following High Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT).

Prior Therapy with Rituximab (R) in Patients with Follicular Lymphoma (FL) Does Not Affect Relapse-Free (RFS) or Overall Survival (OS) after High Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT).

Survival and Predictors of Outcome in Acute Leukemia Patients Admitted to the Intensive Care Unit.

Aggressive Electrolytes Replacement in Multiple Myeloma (MM) Patients Receiving Arsenic Trioxide (ATO) Containing Regimens Alleviates the Need for Frequent Electrocardiogram (ECG) Monitoring.

Bisphosphonate Therapy Associated with an Increased Incidence of Mandibular/Maxillary Osteomyelitis in Multiple Myeloma Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only